CClinicalTrials.gg
Status unknownNCT03575442Updated Oct 10, 2019

"Art Therapy" in Acute Psychiatry

An interventional study of 3 session program of "art therapy" in Schizophrenia, Mood Disorders and Mental Disorder, sponsored by Centro Hospitalar e Universitário de Coimbra, E.P.E.. Status unknown at 1 site in Portugal. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-10.

Sponsored by Centro Hospitalar e Universitário de Coimbra, E.P.E. · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Mar 2019), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Apr 2017, registered May 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
Male
01

Study summary

Background: Given the complexity of this problem, psychiatric in-patients in the acute stage of their disease need different types of therapeutic programs to recover they mental health state. Usually they're submitted to systematic biological programs (namely psychopharmaceuticals), often considered a priority when compared to psychosocial programs. Among the different therapies that have been introduced in this context "art therapy", also named creative therapy, can constitute a treatment that complements the allopathic treatments, providing improvements in self-esteem and self-efficiency, distraction and relief from concerns and negative thoughts. Scientific evidence on the effects of psychosocial programs in the context of hospitalization of acute cases is scarce.

Aims: a) evaluate the effectiveness of a 3 session program of "art therapy" in changing emotional indicators, namely depression, anxiety, stress, and psychological well-being, in individuals with mental illness; b) analyze the meanings a person attributes to his creative self-expression.

Method: This is a pre-experimental, prospective study, with a pre test-post test design without control group, with a mixed approach (quantitative and qualitative). The study was performed in the psychiatry unit (Psiquiatria B), in the Centro Hospitalar e Universitário de Coimbra - Portugal. The target population was composed by men (older than 18), hospitalized in this ward. The exclusion criteria were: individuals with active psychotic symptomology, in manic phase and/or refusing to participate. The instruments used to collect information were: Depression, Anxiety and Stress Scale [DASS-21]; Ryff Scales of Psychological Well-Being (SPWB - 18 item version) and a semi-structured interview.

Data collection and the development of this study occurred in the following manner:

  • Initial evaluation to verify the sample selection criteria in the first 48 hours after patient hospitalization;
  • Obtain informed consent for the application of instruments and participation in the "art therapy" intervention program;
  • Application of instruments (DASS-21 and SPWB-18 item version) before intervention;
  • Development of the program applied as a group, during three weeks, one session a week, each lasting approximately 90 minutes and assisted by a specialist in plastic expression. Each session was held in an occupational therapy room, including all the material deemed necessary for the execution of some of the techniques introduced by the technician. After each session, a semi-structured interview was conducted with each participant in order to analyze the meanings attributed.
  • In the end of the program, the same instruments were reapplied.
02

Conditions studied

  • Schizophrenia
  • Mood Disorders
  • Mental Disorder
  • Nurse-Patient Relations
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Centro Hospitalar e Universitário de Coimbra, E.P.E. is the lead sponsor of 13 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • men (older than 18), hospitalized in a psychiatric unit;
  • capable of communicating and understanding communication;
  • acceptance and commitment to participate in the study;
  • signature of study informed consent.

Exclusion criteria

Exclusion Criteria:

  • individuals with active psychotic symptomology, in manic phase and/or refusing to participate.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Other
    3 session program of "art therapy"

    Development of the program applied as a group, during three weeks, one session a week, each lasting approximately 90 minutes and assisted by a specialist in plastic expression. Each session was held in an occupational therapy room, including all the material deemed necessary for the execution of some of the techniques introduced by the technician. After each session, a semi-structured interview was conducted with each participant in order to analyze the meanings attributed.

    Behavioral: 3 session program of "art therapy"

Interventions

  • Behavioral3 session program of "art therapy"

    With this program, we expect to offer socio-emotional well-being in the psychiatric context, and creative self-expression through painting. In addition, we hope to provide contributions towards the creation of quality standards of the professional practice of nurses, within the context of implementing psychosocial programs in mental health.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in the participant's emotional states of depression, anxiety and stress

    Outcome measure - Depression, Anxiety and Stress Scale \[DASS-21\] - (Lovibond et al.,1995 adapted by Apóstolo, Mendes \& Azeredo, 2006)

    Time frame: Post-intervention assessment (week 3)

  2. Change from Baseline in the participant's psychological well-being

    Outcome measure - Ryff Scales of Psychological Well-Being (SPWB - 18 item version) - (Ryff, 1989 adapted by Novo, Neto, Marcelino \& Santo, 2006)

    Time frame: Post-intervention assessment (week 3)

  3. Semi-structured interview

    Aim: explore in a psychiatric context \[in the acute stage of the disease\] the sick person's experiences related to expression by painting after each of three scheduled interviews, during hospitalization.

    Time frame: Post-intervention assessment (week 3)

07

Study locations

1 site
  • Psiquiatria B - Centro Hospitalar e Universitário de Coimbra
    Coimbra, 3001-301, Portugal
08

References and documents

Publications

  • Stickley T, Hui A. Arts In-Reach: taking 'bricks off shoulders' in adult mental health inpatient care. J Psychiatr Ment Health Nurs. 2012 Jun;19(5):402-9. doi: 10.1111/j.1365-2850.2011.01811.x. Epub 2011 Sep 20. PubMed 22070164 ↗
  • Van Lith, T. Art therapy in mental health: A systematic review of approaches and practices. The Arts in Psychotherapy. 2016; 47: 9-22.
  • Stickley T, Hui A, Morgan J, Bertram G. Experiences and constructions of art: a narrative-discourse analysis. J Psychiatr Ment Health Nurs. 2007 Dec;14(8):783-90. doi: 10.1111/j.1365-2850.2007.01173.x. PubMed 18039303 ↗
  • Davidson, L., Sells, D., Sangster, S., O'Connell, M. Qualitative studies of recovery: What can we learn from the person? In R. Ralph, & P. Corrigan (Eds.), Recovery in Mental Illness - Broadening our understanding of wellness. Washington, 2005, DC: American Psychological Association.
  • Thyme, K., Sundin, E., Stahlberg, G., Lindstrom, B. Eklof, H., Wiberg, B. The outcome of short term psychodynamic art therapy compared to short term psychodynamic verbal therapy for depressed women. Psychodynamic Psychotherapy. 2007; (21): 251-264.
  • Teglbjaerg HS. Art therapy may reduce psychopathology in schizophrenia by strengthening the patients' sense of self: a qualitative extended case report. Psychopathology. 2011;44(5):314-8. doi: 10.1159/000325025. Epub 2011 Jun 9. PubMed 21659793 ↗
  • Blomdahl, C., Gunnarsson, B., Guregard, S., Bjorklund, A. A realist review of art therapy for clients with depression. The Arts in Psychotherapy. 2013; 40(3): 322-330.
  • Montag C, Haase L, Seidel D, Bayerl M, Gallinat J, Herrmann U, Dannecker K. A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS One. 2014 Nov 13;9(11):e112348. doi: 10.1371/journal.pone.0112348. eCollection 2014. PubMed 25393414 ↗
  • Noiseux S, St-Cyr Tribble D, Leclerc C, Ricard N, Corin E, Morissette R, Lambert R. Developing a model of recovery in mental health. BMC Health Serv Res. 2009 May 1;9:73. doi: 10.1186/1472-6963-9-73. PubMed 19409092 ↗
  • Laranjeira C, Campos C, Bessa A, Neves G, Marques MI. Mental Health Recovery Through "Art Therapy": A Pilot Study in Portuguese Acute Inpatient Setting. Issues Ment Health Nurs. 2019 May;40(5):399-404. doi: 10.1080/01612840.2018.1563255. Epub 2019 Apr 3. PubMed 30943062 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03575442
Lead sponsor
Centro Hospitalar e Universitário de Coimbra, E.P.E.
Responsible party
Sponsor
First posted
Jul 2, 2018
Start date
Apr 1, 2017
Primary completion
Mar 1, 2018
Completion
Dec 2020 (estimated)
Last update
Oct 10, 2019

Study contacts

Clara A. Campos, RN
principal investigator · Centro Hospitalar e Universitário de Coimbra, E.P.E.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion